Endothelial Cysteinyl Leukotriene 2 Receptor Expression and Myocardial Ischemia/Reperfusion Injury

Trends in Cardiovascular Medicine

Volumn 18, Issue 7, 2008, Pages 268-273

  Moos, Michael P W ^a   Funk, Colin D ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; G PROTEIN COUPLED RECEPTOR; LEUKOTRIENE RECEPTOR; MEMBRANE PHOSPHOLIPID; MONTELUKAST; PEPTIDOLEUKOTRIENE; PEPTIDOLEUKOTRIENE 2 RECEPTOR; PRANLUKAST; UNCLASSIFIED DRUG; ZAFIRLUKAST;

BLOOD VESSEL PERMEABILITY; HEART MUSCLE ISCHEMIA; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ENDOTHELIUM, VASCULAR; HUMANS; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENES; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; RECEPTORS, LEUKOTRIENE;

EID: 60149101968     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2008.11.009     Document Type: Review

References (37)

1. Adamek A., Jung S., Dienesch C., et al. Role of 5-lipoxygenase in myocardial ischemia-reperfusion injury in mice. Eur J Pharmacol 571 (2007) 51-54
2. Beller T.C., Maekawa A., Friend D.S., et al. Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice. J Biol Chem 279 (2004) 46,129-46,134
3. Carry M., Korley V., Willerson J.T., et al. Increased urinary leukotriene excretion in patients with cardiac ischemia. In vivo evidence for 5-lipoxygenase activation. Circulation 85 (1992) 230-236
4. Ciana P., Fumagalli M., Trincavelli M.L., et al. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J 25 (2006) 4615-4627
5. Di Gennaro A., Carnini C., Buccellati C., et al. Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: a role for transcellular biosynthesis of cysteinyl-leukotrienes. FASEB J 18 (2004) 842-844
6. Early S.B., Barekzi E., Negri J., et al. Concordant modulation of cysteinyl leukotriene receptor expression by IL-4 and IFN-gamma on peripheral immune cells. Am J Respir Cell Mol Biol 36 (2007) 715-720
7. Fang S.H., Zhou Y., Chu L.S., et al. Spatio-temporal expression of cysteinyl leukotriene receptor-2 mRNA in rat brain after focal cerebral ischemia. Neurosci Lett 412 (2007) 78-83
8. Folco G., Rossoni G., Buccellati C., et al. Leukotrienes in cardiovascular diseases. Am J Respir Crit Care Med 161 (2000) S112-S116
9. Frangogiannis N.G., Smith C.W., and Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc Res 53 (2002) 31-47
10. Fujii M., Tanaka H., and Abe S. Interferon-gamma up-regulates expression of cysteinyl leukotriene type 2 receptors on eosinophils in asthmatic patients. Chest 128 (2005) 3148-3155
11. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294 (2001) 1871-1875
12. Funk C.D. Leukotriene modifiers as potential therapeutics for cardiovascular disease. Nat Rev Drug Discov 4 (2005) 664-672
13. Goulet J.L., Snouwaert J.N., Latour A.M., et al. Altered inflammatory responses in leukotriene-deficient mice. Proc Natl Acad Sci U S A 91 (1994) 12,852-12,856
14. Hashizume K., and Black K.L. Increased endothelial vesicular transport correlates with increased blood-tumor barrier permeability induced by bradykinin and leukotriene C4. J Neuropathol Exp Neurol 61 (2002) 725-735
15. Heise C.E., O'Dowd B.F., Figueroa D.J., et al. Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 275 (2000) 30,531-30,536
16. Hui Y., Yang G., Galczenski H., et al. The murine cysteinyl leukotriene 2 (CysLT2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization. J Biol Chem 276 (2001) 47,489-47,495
17. Hui Y., Cheng Y., Smalera I., et al. Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure. Circulation 110 (2004) 3360-3366
18. 1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells. Blood 110 (2007) 3263-3270
19. Jiang W., Hall S.R., Moos M.P., et al. Endothelial cysteinyl leukotriene 2 receptor expression mediates myocardial ischemia-reperfusion injury. Am J Pathol 172 (2008) 592-602
20. Lötzer K., Spanbroek R., Hildner M., et al. Differential leukotriene receptor expression and calcium responses in endothelial cells and macrophages indicate 5-lipoxygenase-dependent circuits of inflammation and atherogenesis. Arterioscler Thromb Vasc Biol 23 (2003) e32-e36
21. Lynch K.R., O'Neill G.P., Liu Q., et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399 (1999) 789-793
22. 4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors. Proc Natl Acad Sci U S A 105 (2008) 16,695-16,700
23. Mellor E.A., Frank N., Soler D., et al. Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: functional distinction from CysLT1R. Proc Natl Acad Sci U S A 100 (2003) 11,589-11,593
24. Mita H., Hasegawa M., Saito H., and Akiyama K. Levels of cysteinyl leukotriene receptor mRNA in human peripheral leucocytes: significantly higher expression of cysteinyl leukotriene receptor 2 mRNA in eosinophils. Clin Exp Allergy 31 (2001) 1714-1723
25. Moos M.P., Mewburn J.D., Kan F.W., et al. Cysteinyl leukotriene 2 receptor-mediated vascular permeability via transendothelial vesicle transport. FASEB J 22 (2008) 4352-4362
26. Negri J., Early S.B., Steinke J.W., and Borish L. Corticosteroids as inhibitors of cysteinyl leukotriene metabolic and signaling pathways. J Allergy Clin Immunol 121 (2008) 1232-1237
27. Nothacker H.P., Wang Z., Zhu Y., et al. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist. Mol Pharmacol 58 (2000) 1601-1608
28. 2 generation by human mast cells. J Biol Chem. 283 (2008) 16,477-16,487
29. Peters-Golden M., and Henderson Jr. W.R. Leukotrienes. N Engl J Med. 357 (2007) 1841-1854
30. Sheng W.W., Li C.T., Zhang W.P., et al. Distinct roles of CysLT1 and CysLT2 receptors in oxygen glucose deprivation-induced PC12 cell death. Biochem Biophys Res Commun. 346 (2006) 19-25
31. Shirasaki H., Seki N., Fujita M., et al. Agonist- and T(H)2 cytokine-induced up-regulation of cysteinyl leukotriene receptor messenger RNA in human monocytes. Ann Allergy Asthma Immunol 99 (2007) 340-347
32. Sjöström M., Johansson A.S., Schröder O., et al. Dominant expression of the CysLT2 receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells. Arterioscler Thromb Vasc Biol 23 (2003) e37-e41
33. Tarnavski O., McMullen J.R., Schinke M., et al. Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiol Genomics 16 (2004) 349-360
34. Tudhope S.R., Cuthbert N.J., Abram T.S., et al. BAY u9773, a novel antagonist of cysteinyl-leukotrienes with activity against two receptor subtypes. Eur J Pharmacol 264 (1994) 317-323
35. Uzonyi B., Lötzer K., Jahn S., et al. Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells. Proc Natl Acad Sci U S A 103 (2006) 6326-6331
36. 4 induces brain edema and enhances CysLT2 receptor-mediated aquaporin 4 expression. Biochem Biophys Res Commun 350 (2006) 399-404
37. Yellon D.M., and Hausenloy D.J. Myocardial reperfusion injury. N Engl J Med 357 (2007) 1121-1135